Intellia Therapeutics NTLA
NASDAQ NTLA
$12.40 +0.34 (+2.78%)
As of: Oct 1, 2026 · 1:01 PM EDT

Intellia Therapeutics (NTLA) Shares Outstanding (Entity) (2015 - 2026)

Updated

Intellia Therapeutics' Shares Outstanding (Entity) was 140.02 million in Q2 2026, up 32.9% from 105.33 million a year earlier and up 16.2% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Entity) at Intellia Therapeutics came in at 116.32 million, up 14.0% from FY2024.

  • Shares Outstanding (Entity) has now increased for nine consecutive years, with a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 102.03 million in FY2024 (+9.7%), 93 million in FY2023 (+6.8%), 87.1 million in FY2022 (+16.9%) and 74.49 million in FY2021 (+12.5%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2015.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 37 straight quarters, with growth averaging 14.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 3.0% in Q3 2022 to 32.9% in Q2 2026.
  • Per Business Quant data, NTLA's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 120.45 million (Q1 2026), 116.32 million (Q4 2025) and 115.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Intellia Therapeutics 1.69 Bn 1.69 Bn - 140.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.02 Mn
Mar 31, 2026 120.45 Mn
Dec 31, 2025 116.32 Mn
Sep 30, 2025 115.79 Mn
Jun 30, 2025 105.33 Mn
Mar 31, 2025 103.54 Mn
Dec 31, 2024 102.03 Mn
Sep 30, 2024 101.80 Mn
Jun 30, 2024 98.29 Mn
Mar 31, 2024 96.33 Mn
Dec 31, 2023 93.00 Mn
Sep 30, 2023 89.10 Mn
Jun 30, 2023 88.35 Mn
Mar 31, 2023 88.10 Mn
Dec 31, 2022 87.10 Mn
Sep 30, 2022 76.59 Mn
Jun 30, 2022 76.00 Mn
Mar 31, 2022 75.62 Mn
Dec 31, 2021 74.49 Mn
Sep 30, 2021 74.34 Mn
API Access

Intellia Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NTLA&period=max&api_key=YOUR_API_KEY